DOT Issues Safety Advisory Notice for the Transportation of COVID-19 Diagnostic Samples
Shipping guidelines for SARS-CoV-2 specimens emphasized as many clinical laboratories are not shipping specimens correctly.
Implications of Revocation of SARS-CoV-2 Serology EUA May Indicate FDA Enforcement That Could Affect Clinical Laboratories’ COVID-19 Tests
With serological assays for SARS-CoV-2 widely available, uncertainty remains around the accuracy of these tests. The revocation of Chembio’s SARS-CoV-2 serology EUA could indicate broader and stricter enforcement by the FDA.